X0306 4 2014-02-12 0 0000816284 CELGENE CORP /DE/ CELG 0001538894 Daniel Thomas O C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 0 1 0 0 see remarks Common Stock 2014-02-12 4 A 0 7594 0.00 A 26662 D Common Stock 2014-02-12 4 F 0 3962 160.54 D 22700 D Common Stock 1395 I 401(k) Plan Phantom Stock 2014-02-12 4 A 0 7594 A Common Stock 7594 7594 D The reporting person was awarded 15,188 shares of common stock pursuant to the 2011-2013 Long Term Incentive Plan under the Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of April 17, 2013). The reporting person deferred the receipt of 7,594 shares of common stock and received instead 7,594 shares of phantom stock pursuant to the Celgene Corporation 2005 Deferred Compensation Plan. Each share of phantom stock represents a right to receive one share of common stock. The phantom stock becomes payable six months following the reporting person's termination of employment with Celgene Corporation. Executive Vice President and President, Research & Early Development /s/Robert J Hugin________________ Robert J Hugin, Attorney-in-Fact 2014-02-14